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Abstract
Plasmodium falciparum, the causative agent of human malaria, invades host erythrocytes using
several proteins on the surface of the invasive merozoite, which have been proposed as potential
vaccine candidates. Members of the multi-gene PfRh family are surface antigens that have been
shown to play a central role in directing merozoites to alternative erythrocyte receptors for invasion.
Recently, we identified a large structural polymorphism, a 0.58 Kb deletion, in the C-terminal region
of the PfRh2b gene, present at a high frequency in parasite populations from Senegal. We hypothesize
that this region is a target of humoral immunity. Here, by analyzing 371 P. falciparum isolates we
show that this major allele is present at varying frequencies in different populations within Senegal,
Africa, and throughout the world. For allelic dimorphisms in the asexual stage antigens, Msp-2 and
EBA-175, we find minimal geographic differentiation among parasite populations from Senegal and
other African localities, suggesting extensive gene flow among these populations and/or immune-
mediated frequency dependent balancing selection. In contrast, we observe a higher level of inter-
population divergence (as measured by Fst) for the PfRh2b deletion, similar to that observed for
SNPs from the sexual stage Pfs45/48 loci, which is postulated to be under directional selection. We
confirm that the region containing the PfRh2b polymorphism is a target of humoral immune responses
by demonstrating antibody reactivity of endemic sera. Our analysis of inter-population divergence
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suggests that in contrast to the large allelic dimorphisms in EBA-175 and Msp-2, the presence or
absence of the large PfRh2b deletion may not elicit frequency-dependent immune selection, but may
be under positive immune selection, having important implications for the development of these
proteins as vaccine candidates.
Keywords
Plasmodium falciparum; Fst; selection; immunity; PfRh2b; antigen
INTRODUCTION
The battle against malaria, a major global health problem, has been complicated by the ongoing
emergence of drug-resistant parasites and insecticide-resistant mosquitoes. Inadequate health
systems and the lack of sustainable infrastructure exacerbate the problem in the countries most
affected by the disease. Among the high priority potential control measures is the development
of a vaccine against malaria. The design of such a vaccine is hampered by extensive genetic
polymorphism in Plasmodium falciparum proteins; in particular, those expressed on the
parasite’s surface that are considered ideal targets for the immune response and the
development of highly specific vaccines (McCutchan 1988; Saul 1994; Conway 1997).
Antigens exposed at the surface of the invasive merozoite form of the parasite, such as the
EBA-175 and Msp-2 proteins, are targets of naturally acquired immunity (al-Yaman 1994),
inducing antibodies that inhibit parasite growth in vitro that are frequently detected in sera
from individuals living endemic areas (Epping 1988; Ramasamy 1990; Sim 1990; Thomas
1990; Ranford-Cartwright 1996; Daugherty 1997; Taylor 1998; Okenu 2000).
Many sequence polymorphisms have been described in the genes encoding asexual stage
antigens. Identifying allele frequencies in antigen genes from different populations has
revealed considerable polymorphism in parasite populations worldwide, which is an important
consideration for vaccine development. Moreover, population genetic analysis of different
malaria vaccine antigens in different populations has shown that Wright’s fixation index (Fst)
is sensitive to the different selection strategies that act on different antigens (Conway 1997;
Escalante 1998; Conway 2000; Silva 2000; Tanabe 2000; Binks 2001; Hoffmann 2001;
Escalante 2002; Polley 2003). Some polymorphic loci, such as the sexual stage antigen
Pfs48/45, have a high Fst value for mean heterogeneity in allele frequencies among populations,
indicating a high degree of population divergence and possible directional selection (Conway
2000; Escalante 2002). Loci like EBA-175 and Msp-2 that are subject to immune-mediated
balancing selection, however, have been shown to exhibit reduced divergence (low Fst)
(Conway 1997; Binks 2001; A A Abdel-Muhsin 2003; Verra 2006). The Fst statistic, therefore,
may be used as a proxy to estimate the degree to which loci are subject to balancing selection
as a result of immune selection.
In addition, dimorphic allelic classes including relatively large stretches of amino acid
sequence have been observed in several antigens, including EBA-175 (F-seg vs. C-seg) and
Msp-2 (IC vs. FC), where the alleles within a class are much less divergent from each other
than from alleles of the other class (Snewin 1991; Ware 1993), although recombination can
occur between the two classes (Roy 2008).
New proteins that are currently being assessed as invasion-blocking vaccine candidates include
members of the PfRh (Plasmodium falciparum reticulocyte binding protein homolog) family
(Rayner 2005). PfRh family members are localized to the apical organelles of the invasive
merozoite and are believed to play a role in the recognition of the erythrocyte and tight junction
formation, the irreversible step in erythrocyte invasion. A recent study assessing variant
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expression and polymorphism in the PfRh proteins in Senegal identified a 0.58Kb deletion in
the unique region of PfRh2b, the region which is predicted to confer binding to the erythrocyte
and subsequent invasion (Jennings 2007).
In the present study, we analyze the distribution and immunogenicity of the large sequence
deletion in the PfRh2b gene, in comparison with large allelic dimorphisms in the Msp-2 and
EBA-175 genes, and SNPs (single nucleotide polymorphisms) in the Pfs45/48 gene, to
investigate the geographic variation in the frequencies of these polymorphisms using
population genetic analyses and to infer the existence of natural selection. Such knowledge
will inform the rational prioritization of vaccine candidates.
MATERIALS AND METHODS
Plasmodium falciparum isolates and collection sites
Peripheral blood samples were collected from 371 P. falciparum-infected individuals in diverse
geographical locations for genotyping of parasite antigen polymorphisms. Samples were
collected from 4 different sites in Senegal: 63 isolates from Pikine (approximately 15 km from
Dakar), 74 isolates from Thies (approximately 70 km from Dakar), 62 isolates from Passy
(central Senegal), and 35 isolates from Velingara (southern Senegal). In addition, samples were
collected in two other African countries: 36 isolates from Malawi and 25 from Tanzania.
Samples from Asia included 18 samples from Thailand and 43 from Malaysia in addition to
15 from Brazil. These samples come from regions of the world with dramatically different
entomological inoculation rates (EIR) that reflect local transmission rates: Pikine (EIR=1),
Thies (EIR=10), Passy (EIR>100), Velingara (EIR>100), Malawi (EIR>200), Tanzania
(EIR>200), Brazil (EIR = 2–20) Thailand and Malaysia (EIR undetermined). All samples were
obtained with informed consent from patients and guardians and the studies received ethical
clearance from ethical committees of all collaborating institutes and governments.
DNA extraction and genotyping
Parasite DNA was extracted from blood or from filter paper using QIAmp DNA Minikit
(Qiagen, Valencia, CA, USA). The EBA-175 F-seg/C-seg genotype was determined by nested
polymerase chain reaction (PCR) as described elsewhere (Toure 2001). The Pfs48/45
polymorphisms were amplified by PCR followed by restriction fragment length polymorphism
(RFLP) with NlaIII and HpaI as previously described (Drakeley 1996). PCR-based Msp-2
genotyping was performed as previously described (Snounou 1999).
For the PfRh2b deletion, the following primers were used to amplify a gene fragment including
the deletion using a hemi-nested PCR strategy, (forward primer: 5′ TAA TGA TAT AAA GGA
TCT TGG TGA 3′, reverse primer: 5′ AGG AAA TCA TCC ATT TTG TTA TGG T 3′), PCR
was carried out using the following conditions: initial 2-min denaturation at 94°C followed by
25 cycles with 20-s at 94°C, 20-s at 55°C and 2-min at 72°C and 2-min final extension at 72°
C. For the second PCR, (forward primer: 5′ GGA TAA AAT ACT AGA AGG AAG TGA 3′,
reverse primer: 5′ AGG AAA TCA TCC ATT TTG TTA TGG T 3′), PCR was carried out
using the following conditions: initial 2-min denaturation at 94°C followed by 30 cycles with
2-s at 95°C, 2-s at 55°C and 30-s at 72°C and 2-min final extension at 72°C. All amplicons
were separated on 1% agarose gel, stained with ethidium bromide and visualized using UV-
trans illumination.
Population genetic analysis
To determine the extent of geographic variation in the frequencies of alleles, we employed
Wright’s fixation index (Fst). Calculations were made as previously described (Drakeley
1996). Because mixed infections are not uncommon in highly endemic populations, we
Ahouidi et al. Page 3
Infect Genet Evol. Author manuscript; available in PMC 2011 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
calculated the allele frequencies for bi-allelic populations using the following formula: for
allele A = (no. of A isolates + (0.5 * no. of AB isolates)/(total no. of isolates) and allele B =
(no. of B isolates + (0.5 * no. of AB isolates)/(total no. of isolates). Similarly for the tri-allelic
locus, the following formula was used: for A= (no. of A isolates + (0.5 * no. of AB isolates)
+ (0.5* no. of AC isolates)/(total no. of isolates), for B = (no. of B isolates + (0.5 * no. of AB
isolates) + (0.5* no. of BC isolates)/(total no. of isolates), and for C = (no. of C isolates + (0.5
* no. of AC isolates) + (0.5* no. of BC isolates)/(total no. of isolates). To explore associations
in allele frequencies between different genes for different regions in Senegal, Fisher’s exact
test was applied. This method for estimating allele frequencies is inherently biased due to the
multiplicity of infection (multiclonality) found in many isolates of P. falciparum. The tendency
of the bias is to force allele frequencies closer to 0.5 (50%) in samples composed of many
mixed infections of high MOI. As a result, this approach will tend to underestimate the degree
of divergence between populations due to heterogeneity in allele frequency between
populations being smoothed away. This will create the illusion that loci not subject to balancing
selection are actually maintained at intermediate allele frequencies in multiple populations,
thereby decreasing the contrast in an Fst analysis. If a contrast in Fst between different loci is
still observed despite this bias, the inference of immune-mediated balancing selection is
conservative. In addition, though the estimates of allele frequency (and consequently Fst) are
incorrect in absolute terms, they are comparable among loci due to similar sample sets used
for each locus.
Antigens
The PfRh2b unique domain was amplified from 3D7 genomic DNA, cloned into pGEX-2T
vector (Promega) and expressed as a GST-fusion protein in BL21 DE3 Rosetta pLysS cells
(Novagen). Protein was purified with Glutathione sepharose columns, concentrated and stored
in PBS. GST protein (pGEX-2T without insert) was expressed, purified, and used to determine
non-specific background reactivity.
Endemic Sera
Plasma was obtained from patients in Senegal and Tanzania with uncomplicated malaria during
the transmission season after informed consent was obtained. Patient plasma was collected in
a highly endemic region of Senegal (n=67) and a highly endemic region of Tanzania (n=36),
both having EIR>100. Seventy-two unexposed sera, obtained from Brigham and Women’s
Hospital, Boston, MA, were used as controls.
Enzyme-linked immunosorbent assay
To measure IgG response against PfRh2b, microtiter plates were coated with 300ng of GST-
PfRh2b in PBS at 4°C overnight. Plates were blocked with 1% milk in PBST (1X PBS + 0.05%
Tween-20) for 1 hour at room temperature and washed 3 times with PBST. Individual plasma
were added in duplicate at 1/800 dilution and incubated for 2 hours at room temperature. After
washing 3 times with PBST, goat anti-human total IgG HRP-conjugated secondary antibodies
(Southern Biotech) were added at 1/8000 dilution and incubated at room temperature for 2
hours. Plates were washed 5 times with PBST, developed using Sureblue TMB one-component
substrate (KPL 52-00-02), and the reaction was stopped with 1N HCl. ELISA plates were read
at 450nm. The positive cut-offs for PfRh2b was determined as an OD 3 times the standard
deviation of the mean of the seventy-two unexposed Boston plasma.
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RESULTS
Polymorphisms in PfRh2b, Msp-2, EBA-175 and Pfs48/45 are present at high frequency in
Senegal and in populations throughout the world
The goal of this study was to determine the frequency of a novel polymorphism, the PfRh2b
deletion, in the context of other well described polymorphisms in current vaccine candidate
antigens (Figure 1). The PfRh2b deletion was present at a high frequency, ranging between
0.63 and 0.72, in all four sites in Senegal (Pikine, Thies, Velingara and Passy) (Table 1). The
high frequency of this recently described polymorphism was intriguing and prompted our
analysis in other countries within Africa and worldwide. The PfRh2b deletion was found at
similar high frequencies in Tanzania, Malaysia and Malawi (0.87, 0.84 and 0.58 respectively),
but in Thailand and Brazil the frequency was dramatically lower (0.10 and 0.08 respectively).
We next sought to compare the frequencies of the PfRh2b deletion with those of
polymorphisms in other known malaria vaccine candidate antigens. Analysis of the
EBA-175 dimorphic alleles from different geographical regions in Senegal revealed that in
Thies and Pikine the predominant allele was F-segment (0.62 and 0.76 respectively), while in
Passy and Velingara, the frequency of C-segment was predominant (0.53 and 0.51
respectively). The C-segment was found at the same frequency in Malawi and Tanzania and
Malaysia (0.56) and at a high frequency in Brazil. However, in Thailand, the C-segment was
observed at a low frequency (0.29) (Table 1).
For the Msp-2 locus, the IC dimorphic allele was predominant in all sites in Senegal, and in
Brazil, Thailand and Malawi (Table. 1); whereas, in Tanzania and Malaysia the frequencies
were lower at 0.46 and 0.28 respectively.
The results of Pfs48/45 analysis show that the predominant allele in the four Senegalese
locations was type IIc, with a frequency between 0.86 and 0.95. The other two alleles were
present at lower frequencies and type IIa2 was not found in Velingara. The type IIc was
predominant in Tanzania and Malawi; however, IIa1 was predominant in Thailand and
Malaysia, and IIa2 in Brazil (Table 1).
Applying Fisher’s exact test indicates that there was no association between allelic forms of
PfRh2b, EBA-175, Pfs48/45 or Msp-2 in the Senegalese or in the global isolates (data not
shown). Using the Mann-Whitney U test, we found no association between age or seasonality
and the presence of deletion in Senegal (data not shown).
Geographical differentiation of dimorphisms between populations within Senegal, Africa and
worldwide
Fst was calculated from allele frequencies to measure the genetic differentiation between the
different populations. For the PfRh2b polymorphism, the inter-population Fst value was low
between the Senegalese populations, and remained low when we included other African
countries in the analysis (Table 2). By comparison, the Fst indices for the EBA-175 and the
Msp-2 dimorphisms were also low within Senegal, and between the African countries. Within
Senegal, the Fst index for Pfs48/45 was low (0.020); however, when we calculated the Fst
including African countries the value was higher (0.070).
The combined data from all global populations considered in this study—African populations,
South East Asian and Latin American populations—demonstrate a higher Fst value for the
PfRh2b polymorphism, when compared to the African populations alone: the Fst value of
combined African populations and South East Asian populations was six times greater than
the value for African populations. The increased Fst values when moving from African to global
isolates was similar to that seen for the Pfs48/45 polymorphisms. Although higher Fst values
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are also observed for EBA-175 and Msp-2 dimorphisms compared with African populations
alone, these values are significantly lower than those observed for the PfRh2b and Pfs48/45
polymorphisms, suggesting less genetic differentiation of these alleles (Table 2). Similar trends
are observed when only monoclonal infections are used to estimate allele frequencies
(Supplementary Figure 1), although the numbers of samples to estimate frequency in each
population is much reduced.
Recognition of PfRh2b by human antibodies and influence of age on antibody response
The presence of the PfRh2b deletion worldwide prompted us to determine whether antibodies
against the C-terminal region of PfRh2b exist, and could act as a selective pressure on this
locus. We measured IgG responses against a unique region of PfRh2b and found that positive
antibody responses exist in both Senegal and Tanzania (Figure 3A) and are acquired in an age-
dependent manner, although not statistically significant by Kruskal-Wallis (p=0.17) (Figure
3B). This result implies that the humoral immune response could potentially select parasites
harboring the PfRh2b deletion if such parasites invoked a reduced immune response relative
to parasites with intact PfRh2b proteins.
DISCUSSION
It has become very clear that substantial genetic differentiation exists between parasite
populations in Asian and African isolates (Volkman 2007; Neafsey 2008). Here we report the
assessment of a new structural polymorphism, a large deletion in the P. falciparum erythrocyte
invasion ligand PfRh2b, a dominant invasion ligand involved in sialic-acid independent
invasion of erythrocytes. In addition to showing that it is widespread throughout the world, we
further provide evidence that it elicits a humoral response which could be the selective pressure
driving its frequency.
Using a population genetic analysis, we show that although the PfRh2b deletion is present
worldwide, it appears to vary in frequency significantly in different populations. Our results
show that the frequency of the deletion is high in all study sites with the exception of Thailand
and Brazil. When calculating Fst for the PfRh2b deletion globally, the Fst value was very
comparable to that observed for polymorphisms in Pfs48/45, which have been previously
shown to be under directional selection (Conway 2000; Escalante 2002). There was no evidence
from the inter-population variance that the PfRh2b polymorphism is under balancing selection
globally. However, Fst calculation using only Senegalese sites revealed a value very close to
zero (0.009), a similar result is found when only African sites are analyzed. This low Fst
indicates little genetic differentiation, or divergence among African populations. Indeed,
similar values were seen for all of the allelic polymorphisms considered in our study, suggesting
the presence of significant gene-flow within the continent, similar to previous observations
(Awadalla 2001).
The dramatic difference in the PfRh2b deletion frequencies in Brazil and Thailand population
compared with the other populations invites the speculation the genetic background of the host
in these populations may influence the allele frequencies, due to the presence of different
erythrocyte receptor polymorphisms. Alternatively, the PfRh2b deletion may have originated
in Africa, and could be at low frequency in Asian and American populations because it is has
only recently arrived in those locations. We have some evidence that the PfRh2b deletion is
associated with the use of protease-sensitive erythrocyte receptors for invasion (Lantos
2009). Previous studies have shown that parasite lines from different geographic areas express
PfRh proteins variantly (Taylor 2002; Duraisingh 2003; Nery 2006; Bei 2007). This variation
in expression may also possibly contribute to the fact that the PfRh2b polymorphism does not
appear to be under balancing selection since alternative ligands can compensate for
polymorphism in PfRh2b.
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The PfRh2b deletion was previously described in only one lab strain, T9/96, from Thailand,
and more recently in Senegalese isolates (Jennings 2007). The high prevalence of the deletion
in many global populations may suggest that appearance of the deletion in the field is not recent;
however, to test this hypothesis we need to measure the distribution of the PfRh2b deletion
using matched archival and recent samples from the same region, or follow the prevalence in
specific sites over time. The absence of the deletion in other lab strains, most of which were
established in the 1980s, may on the other hand suggest that the deletion has spread recently.
We investigated if specific immune responses exist against the PfRh2b C-terminal region that
harbors the PfRh2b deletion polymorphism. We hypothesize that the parasite has the ability to
utilize two potential mechanisms for evading the immune response: variant expression and
polymorphism. To test these hypotheses, we measured the IgG response to PfRh2b using sera
from Senegal and Tanzania. The presence of an antibody response against the invasion ligand
PfRh2b may be significant as these antibodies may be inhibitory to erythrocyte invasion. We
found that antibodies against PfRh2b exist in Senegalese and Tanzania sera. The percentage
of positive antibody responses by cut-off is similar in both sites, and the acquisition of antibody
is correlated with increasing patient age. Such findings imply that this locus is recognized by
the humoral immune response, which may serve as a selective force driving the frequency of
the PfRh2b deletion if the deletion allele invokes a weaker response than the wild-type allele.
Allele specificity of the immune reactivity, measured by competitive ELISA using the PfRh2b
wildtype and deletion polymorphism, would further strengthen the hypothesis of immune
selection. It has yet to be determined whether immune responses to the PfRh2b unique domain
are inhibitory and whether the deletion contributes to immune evasion.
Our results show global variation in the genetic distribution of the PfRh2b deletion and
Pfs48/45 polymorphisms, while the frequency distribution of the deletion seems similar in
Africa, it is quite divergent worldwide relative to polymorphisms in antigens known to be
subject to balancing selection, implying that this polymorphism may not be subject to strong
balancing selection, or may be exposed to variable selection pressures across sites.
Alternatively, the PfRh2b deletion may exhibit higher divergence among worldwide
populations than the Msp-2 and EBA-175 polymorphisms because it is a younger allele, and
has not had as much time to spread throughout the range of the parasite populations. We
consider this unlikely due to the observation that the PfRh2b deletion is found at frequencies
comparable to the Msp-2 and EBA-175 polymorphisms in African and Malaysian populations,
whereas a younger allele would more likely be present at lower frequencies. Our findings imply
that inclusion of antigens with such profiles may be efficacious in some, but not all countries,
resulting in limited vaccine utility. In contrast, Msp-2 and EBA-175 are also involved in
erythrocyte invasion, yet in our study, the EBA-175 and Msp-2 dimorphisms exhibit minimal
genetic differentiation globally. This strongly suggests that they are under balancing selection,
a criteria for inclusion in a universally applicable vaccine.
This population genetic study demonstrates that focusing on large sequence dimorphisms and
deletions as vaccine candidates may prove to be an effective strategy for vaccine design. These
large regions may inherently define discrete domains that can elicit protective antibody
responses (Conway 1997). Using such molecular population genetic analyses to predict a
region of selection, and validating this region using molecular and immunological tools, is an
effective approach to identifying novel antigenic regions. This could be exploited in vaccine
development, particularly by including both dimorphic regions in combination.
In our study we focus on a comparison of different antigens that are presumably all under
selection either by humoral immunity or by red blood cell polymorphisms. We have chosen to
focus on antigen polymorphisms for which data previously exists as controls for the
measurement of genetic differentiation, known to be either under balancing selection (Msp-2)
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or directional selection (Pfs48/45). We realize that an expanded study comparing these antigen
loci with SNPs in putative neutral loci or in drug-resistance loci may be informative (Anderson
2005).
In conclusion, it has been suggested that a good vaccine candidate would incorporate a region
of a protein with very few allelic forms under strong balancing selection (Conway 1997). Our
results suggest that in contrast to the EBA-175 and Msp-2 dimorphisms, the PfRh2b deletion
may not be under balancing selection globally. However, the C-terminal region of PfRh2b
harboring the PfRh2b deletion does elicit immune responses that may exert directional
selection on the polymorphism. Further studies will determine whether naturally acquired
antibodies to PfRh2b in endemic populations can functionally inhibit invasion. To our
knowledge, large deletions on the order of 500bp have not been previously identified in other
Plasmodium antigens; however small deletions on the order of 39bp are present in Msp-3
(McColl 1997). It will be of interest in the future to determine whether these deleted regions
in other antigens are also more genetically differentiated between populations, suggesting that
in general, large sequence deletions arise as a mechanism to avoid frequency-dependent
immune selection.
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Figure 1. Polymorphic alleles of vaccine candidate antigens
Schematic of the polymorphic alleles of genes in this study. (A) PfRh2b with large C-terminal
deletion, (B) EBA-175 with F-segment and C-segment large allelic dimorphisms, (C) Msp-2
with IC and FC large allelic dimorphisms, and (D) Pfs48/45 single nucleotide polymorphisms
with define the IIa1, IIa2, and IIc alleles.
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Figure 2. Allele frequencies in Senegal and worldwide
Minimal variation in the frequency of a novel polymorphism in PfRh2b is observed in various
regions of Senegal (A), whereas striking variation is observed worldwide (B). PCR typing of
genomic DNA from global parasite isolates was used to determine the allele frequencies. This
result represents the first comprehensive description of PfRh2b deletion frequency in field-
isolated parasite populations.
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Figure 3. Immune responses against PfRh2b exist in two geographically distinct populations
(A) Percent positive responses (defined as OD responses greater than 3 times the standard
deviation of the mean of 72 unexposed Boston sera) for Senegal (n=67) and Tanzania (n=36).
In Senegal, 8.96% of sera had positive IgG titers against PfRh2b; in Tanzania, 5.55% percent
of sera were positive. (B) IgG against PfRh2b is acquired in an age-dependent manner; however
mean differences were not statistically significant by Kruskal-Wallis (p=0.17)
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